The role of the multi-disciplinary team in RAASi optimisation for cardiorenal protection | This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only.
22 Oct 2025
Cardiovascular Professional Care Theatre
- Understand the risks associated with RAASi down-titration or discontinuation
- Discuss some of the barriers to RAASi optimisation, including hyperkalaemia
- Explore a practical patient case study demonstrating an approach to enabling optimisation of guideline-directed RAASi therapy
- Recognise the importance of the multi-disciplinary team in improving patient outcomes
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
.png/fit-in/1280x9999/filters:no_upscale())
){kind=logo}
){kind=logo}
